Orion Corp (OTCMKTS:ORINY) – Jefferies Group raised their FY2017 earnings estimates for shares of Orion in a research report issued to clients and investors on Monday. Jefferies Group analyst J. Vane-Tempest now expects that the company will post earnings of $0.98 per share for the year, up from their previous forecast of $0.97. Jefferies Group also issued estimates for Orion’s FY2018 earnings at $0.98 EPS, FY2019 earnings at $0.97 EPS, FY2020 earnings at $0.93 EPS, FY2021 earnings at $0.94 EPS and FY2022 earnings at $1.03 EPS.
Separately, Zacks Investment Research raised shares of Orion from a “hold” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Saturday, November 11th.
WARNING: This news story was originally published by Week Herald and is owned by of Week Herald. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://weekherald.com/2018/02/15/brokers-offer-predictions-for-orion-corps-fy2017-earnings-oriny.html.
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs.
Receive News & Ratings for Orion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion and related companies with MarketBeat.com's FREE daily email newsletter.